The Use of Serum hCG as a Marker of Tumor Progression and of the Response of Metastatic Urothelial Cancer to Systemic Chemotherapy.
| Publicado en: | Oncology (08909091) Vol. 27; no. 10; pp. 1028 - 1030 |
|---|---|
| Autores principales: | , , , , |
| Formato: | case study pictorial tables/charts Journal Article |
| Publicado: |
MJH Life Sciences
Oct2013
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=91745009&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 91745009 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 08909091 YYT jtl: Oncology (08909091) issn: 08909091 maglogo: N pubinfo: dt: Oct2013 vid: 27 iid: 10 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 91745009 91745009 107934503 91745009 ppf: 1028 ppct: 2 formats: fmt: @attributes: type: P tig: atl: The Use of Serum hCG as a Marker of Tumor Progression and of the Response of Metastatic Urothelial Cancer to Systemic Chemotherapy. aug: au: MALKHASYAN, KAREN DESHPANDE, HARI A. ADENIRAN, ADEBOWALE J. COLBERG, JOHN W. PETRYLAK, DANIEL P. affil: Yale-New Haven Hospital, New Haven, Connecticut sug: subj: Gonadotropins, Chorionic Blood Bladder Neoplasms Radiography Neoplasm Metastasis Radiography Neoplasm Metastasis Therapy Lung Neoplasms Radiography Disease Progression Middle Age Female Bladder Neoplasms Surgery Neoplasm Recurrence, Local Tomography, Emission-Computed Lung Neoplasms Therapy Chemotherapy, Adjuvant Treatment Outcomes Middle Aged: 45-64 years Female pubtype: Academic Journal doctype: case study pictorial tables/charts Journal Article ougenre: Unknown ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|